The pharmaceutical industry resides on a terrain riddled with ethical landmines across research, product development, AI-enabled technologies, manufacturing, and commercialization over which pharma, biotech, and other life sciences companies must tread lightly.
Fujifilm Holdings America Corporation recognized it was no exception and decided to take a proactive

